JOINING US TODAY FOR PREPRINTSAND PUBMED CENTRAL PMC.
I'M REBECCA NATIONAL NETWORK OF LIBRARIES OF
MEDICINE TRAINING OFFICE.
I'M PLEASED TO INTRODUCE KATY
FUNK.
KATY IS THE PROGRAM MANAGER FOR
PUBMED CENTRAL ALSO KNOWN AS PMC
AT THE NATIONAL LIBRARY OF
MEDICINE.
SHE'S RESPONSIBLE FOR PMC POLICY
AS WELL AS PMC'S ROLE IN
SUPPORTING THE PUBLIC ACCESS
POLICIES OF NUMEROUS FUNDING
AGENCIES INCLUDING NIH.
PRIOR TO COMING TO NLM, KATY
WORKED IN ACADEMIC PUBLISHING
MOST RECENTLY AT THE AMERICAN
PSYCHOLOGICAL ASSOCIATION.
AND I AM GOING TO PASS HER THE
BALL IN JUST A MOMENT SO THAT
SHE CAN SHARE HER SCREEN.
AND NOW THAT SHE'S SHARING HER SCREEN, GIVE ME ONE MOMENT,
KATY. NOW THAT KATY'S SHARING HER
SCREEN I WANT TO RE-ORIENT YOU WHAT'S GOING ON.
CHAT HAS MOVED AROUND.
YOU SEE A LITTLE BLUE TAB
HANGING DOWN FROM THE TOP OF THE
SCREEN THAT SAYS VIEWING KATY
FUNK'S DESK TOP.
IF YOU HOVER YOUR MOUSE UP TO
THAT BLUE TAB THE TAB WILL DROP
DOWN AND YOU'LL BE ABLE TO CLICK
ON PARTICIPANTS AND CHAT AGAIN
EOPEN THAT AND THERE'S A
PICTURE OF THAT ON THE SLIDES
THERE.
THANKS FOR DOING THAT, KATY, AND
THAT SHOULD BRING EVERYBODY BACK
INTO THE FOLD AND REMEMBER TO
PUT YOUR QUESTIONS AND COMMENTS
TO ALL PARTICIPANTS, PLEASE.
TAKE IT AWAY, KATY.
>> ALL RIGHT.
THANKS, REBECCA.
APOLOGIES UP FRONT FOR THE VERY
UNEXCITING WEBINAR NAME.
I WENT FOR INFORMATIONAL RATHER
THAN CREATIVE ON THIS BUT WEREALLY APPRECIATE YOU JOINING US
TODAY.
I'M VERY DELIGHTED TO HAVE THIS
OPPORTUNITY TO ENGAGE THE
MEDICAL LIBRARY COMMUNITY ON THE
TOPIC OF PREPRINTS AND THEY' INCLUSION ON RESOURCES SUCH AS
PUBMED CENTRAL.
FOR ME THIS WEBINAR IS ABOUT THE
SHARING AND EXCHANGE OF
INFORMATION AND IDEAS AND
BUILDING A CULTURE OF
COLLABORATION AROUND PREPRINTS.
I DON'T CONSIDER MYSELF THE
WORLD'S FOREMOST AUTHORITY ON
THE TOPIC NOT TO UNDERCUT MY
CREDIBILITY OUT OF THE GATE BUT
I THINK THERE'S A LOT WE HAVE TO
LEARN FROM EACH OTHER SO ILOOKING FORWARD TO THIS.
THERE SEEMS TO BE A LOT OUT
THERE AS TO RESEARCHER
PERSPECTIVES ON PREPRINTS AND
AUTHOR PERSPECTIVES.
WHAT WE'LL TOUCH ON TODAY BUT
THE VIEWS OF OTHER STAKEHOLDERS
SUCH AS LIBRARIANS, AUTHORS
YOU'LL NOTICE ARE ABSENT.
THERE'S GOING TO BE A LARGE
CONTEXTUAL COMPONE HOPING TO LEARN ABOUT AND FROM
YOUR PERSPECTIVES AS WE START
DOWN THIS PATH.
THIS PREPRINT PATHME NEAR THE END OF 2019 WHEN NLM
BEGAN MORE ACTIVELY ENGAWITH THE PREPRINT COMMUNITY AND
WHERE WE FIT IN THE LANDSCAPE.
TO THAT END I WAS AT A WORKSHOP
ON FAIR AND TRANSPARENT
PREPRINTS ON BIOLO MEDICINE ORGANIZED IN JANUARY.
IT WAS A GREAT WORKSHOP AND
YOU'VE BEEN TO THESE THINGS.
EVERYONE LEAVES FEELING INSPIRED
AND WE'RE GOING TO SOLVE ALL THE
WORLD'S PROBLEMS BUT YOU
FREQUENTLY GET BACK TO YOUR
OFFICE AND YOUR INBOX AND
OBLIGATIONS AND THEY KIND OF TAPER OFF.
IT WASN'T CLEAR WHHAPPEN WITH PREPRINTS OUT OF THE
WORKSHOP.
AS I WAS SITTING IN THE AIRPORT
JANUARY 23 WHERE THE NEWS OF WUHAN BEING ON LOCKDOWN BROKE.
I THOUGHT THAT'S INSANE.
I DID NOT THINK IN TWO MONTHS
I'LL BE SITTING IN LOCKDOWN
MYSELF TALKING ABOUT PREPRINTS.
BUT HERE WE ARE.
AND IT WAS THE FOLLOWING DAY,
JANUARY 24 WHEN I WAS BACK IN MY
OFFICE AND PREPRINTS BECAME
HEADLINE NEWS.
AS REPORTED IN THE WASHINGTON
POST THAT DAY, NIH SCIENTISTS
POSTED A PREPRINT OF THEIR ANALYSIS OF THE CORONAVIRUS
GENOME THAT HAD BEEN MADE
AVAILABLE IN NLM DATABASE 12 DAYS PRIOR SHOWING THE
CORONAVIRUS USED THE SAME DOOR
TO GET INTO HUMAN CELLS AS SARS.
A CHINESE TEAM OF SCIENTISTS WAS
ABLE TO VALIDATE AN POST THEIR FINDINGS AS A
PREPRINT 12 HOURS LATER.
IN THE ENSUING MONTHS WE'VE SEEN
MORE AND MORE THEIR PREPRINTS ON COVID-19
SHARING THOUSANDS OF PAPERS
OPENLY AND IMMEDIATELY.
WE'VE ALSO SEEN THE MEDIA ALWAYS
NOT ACCURATELY REPORT THESE
FINDINGS IN THE NEWS.
A GROUP OF PUBLISHERS HAVE BEEN
ASKING ALL POTENTIAL REVIEWERSTO HIGHLIGHT AND IDENTIFY
IMPORTANT COVID-19 PREPRINTS AS
EARLY AS POSSIBLE.
AT LEAST ONE FUNDER, FAST GRANTS
SEEKING TO QUICKLY FUND COVID-19
RESEARCH SET THE EXPECTATIONS
THE RESULTS WILL BE SHARED AS
PREPRINTS.
FINALLY, WE'RE ALSO SEEING YOUR
COMMUNITY, PUB RESEARCHERS, FIND
THIS RESEARCH AND MAKE CALLS TO
NLM TO S DISCOVERABILITY MUCH THIS
CONTENT.
SO WHILE THE AIM OF THIS
PRESENTATION IS NOT TO DO A DEEP
ANALYSIS OF HOW COVID-19 I IS NOT CHANGING COMMUNICATION,
FRANKLY, IT'S PROBABLY TOO EARLY
TO DO THAT AND THINK WE ALL NEED
A BREAK FROM THINKING ABOUT
COVID-19, BUT I DO THINK IT'S
IMPORTANT TO ACKNOWL REALLY AMAZING TO SEE THE
STAKEHOLDER GROUPS COALESCE
AROUND PREPRINTS AS A PART OF
COMMUNICATING SCWE HAVE AN OPPORTUNITY RIGHT NOW
TO BEGIN ASKING WHETHER THE
CURRENT MOMENTUM IS SOMETHING WE
CAN AND SHOULD BUILD ON ACROE RESEARCH SPECTRUM AND IF SO,
WHAT ARE THE MOST EFFECTIVE WAYS
OF DOING SO.
SO TODAY WHAT I'D LIKE TO DO IS
TAKE A STEP BACK AND LOOK AT
PREPRINTS IN THE BIO MEDICAL AND
LIFE SCIENCES BEYOND COVID ANDWE CAN BUILD AROUND THE
BENEFITS, CHALLENGES AND
OPPORTUNITIES PARTLY IN THE
CONTEXT OF NLM PROJECTS IN OURRELATIONSHIP WITH NLM.
TO DO THIS I THINK IT HELPS TOL BE WORK FROM A SHARED
DEFINITION AND I DON'T WANT TOGET TOO [INDISCERNIBLE] IN THIS
PRESENTATION BUT SHOWE BEGAN PREPRINT DISCUSSIONS AT
NLM I ATTENDED APREPRINTS AND IT FELT LIKE EVERY
PRESENTER INCLUDING MYSE KICKED OFF WITH THEIR OWN
DEFINITION OF WHAT A PREPRINT
WAS TO THEM AND EACH ONE WAS A LITTLE BIT DIFFERENT.
SOME OF THAT COULD BE DISCIPLINE
SPECIFIC AND SOME COMES DOWN TO
INHERITING A MESSY TERMINOLOGY
FROM A PRINT WORLD AND APPLYING
IT TO A DIGITAL ONE BUT THERE'S
CHARACTERISTICS MOST AGREE ON SO
WE'LL HIT THOSE REAL QUICK.
BECAUSE IT IS SLIPPERY, I
THOUGHT FIRST WE WOULD KIND OF LOOK AT IT IN THE CONTEXT OF
WHAT A PREPRINT IS NOT SO WE'RE
ON THE SAME PAGE THERE.
I KNOW IT'S OCCASIONALLY
CONFUSED WITH THE POSTPRINT
ACCEPTED FOR PUBLICATION IN A
JOURNAL.
AT NLM WE WOULD REFER TO THAT AS
THE ACCEPTED MANUSCRIPT FOR THE
VERSION TO WHICH THE NIH PUBLIC
POLICY APPLIES.
THE KEY DIFFERENCE BETWEEN THE
PREPRINT AND POSTPRINT ONE IS
GONE THROUGH PEER REVIEW AND ONE
IS NOT AND THERE'S A DIFFERENT
DOI ASSIGNED BY THE PREPRINT
SERVER IT'S BEEN POSTED TO AND
THE AUTHOR HAS THE SAME DOI AS
THE PUBLISHER VERSION.
INSTEAD OF CONTINUING TO MAKE UP
MY OWN DEFINITION I TRANSITIONED
TO HIGHLIGHTING THIS ONE FROM
THE COMMITTEE ON PUBLICATION ETHICS WHICH I THINK HITS THE
HIGH POINTS.
WHEN WE TALK ABOUT PREPRINTS
WE'RE TALKING ABOUT A SCHOLARLY
MANUSCRIPT MADE AVAILABLE IN AN
OPEN PLATFORM BEFORE IT IS PEER
REVIEWED OR CONCURRENTLY WITH
PEER REVIEW.
THERE'S BEEN A PROLIFERATION OF
THESE PLATFORMS WHERE A PREPRINT
MAY BE POSTED AND THROUGHOUT THE
SESSION I'LL REFER TO THE
DISTINCTIONS BUT VARIETY IS THE
SPICE OF LIFE AND THIS IS TRYING
TO CAPTURE THE SCOPE UP TO 50
PLUS PREPRINT SERVERS TO THIS
POINT BUT I'D LIKE TO BREAK THE
ECO SYSTEM INTO TWO PRIMARY
TIMES AND HIGHLIGHT EXAMPLES OF
EACH.
FIRST THERE ARE THE
DISCIPLINED-BASED REPOSITORIES
THINK OF AS THE
TRADITIONAL PREPRINT SERVER
MODEL.
THIS WAS ESTABLISHED IN PHYSICS
AND MATHEMATICS BY ARCHIVE IN
1991 AT CORNELL WHICH
ESTABLISHED IN VARIOUS PREPRINT
CULTURES IN THOSE FIELD.
SINCE SENACXIV INCLUDED SUBSETS
INCLUDING Q BIO.
IT'S ONE TO HAVE ON YOUR RADAR.
PREPRINT SERVERS AND PREPRINT
CULTURE MORE GENERALLY IS MORE
RECENT IN THE BIOLOGICAL
SCIENCES AND STARTED TO TAKE
HOLD FOLLOWING THE LAUNCH OF BIO
ARCHIVE IN 2013 AND OTHERS HAVE
EMERGED SUCH AS CHEMRXIV ANDDICINE AND HEALTH LAST YEAR.
THE OTHER TYPE OF PLATFORMS KIND
OF FALL INTO A VARIETY OF
BUCKETS.
THERE'S THE PUBLISHER INTEGRATED
SYSTEM SUCH AS THE END REVIEW
PLATFORM HOSTED BY RESEARCH
SCARE.
THAT ONE'S BEEN INTEGRATED INTO
THE JOURNAL SUBMISSION WORK
FLOWS.
SO AUTHORS CAN OPT-IN WHEN THEY
SUBMIT TO THE JOURNAL AND THE
FIXTURES AND ZENOOBS WHICH ARE BROADER IN THE CONTENT IN THE
POSTS.
THOSE AREN'T JUST PREPRINTERS YOU CAN POST A PREPRINT
AND DATE AND SOFTWARE, ETCETERA.
THE GROWING CULTURE OF PREPRINT
SHARING IN THE BIO MEDICAL AND
LIFE SCIENCES IS APPARENT IN THE
CHART WHICH IS MADE AVAILABLE BY
ASAPBIO AND IT WAS INCREASING IN
POPULARITY EVEN BEFORE THE
NAVIRUS CHANGED EVERYTHING
AND THIS STARTED WITH THE LAUNCH
OF BIO ARCHIVE BUT THE ORANGE
SQUARE AND WE'LL SEE GROWTH IN
WHAT'S AVAILABLE IN MED ARCHIVE
IN THE COMING MONTHS.
THOUGH PREPRINT SERVERS KEEP
EMERGING AND THE POSTING
CONTINUES TO INCREASE ON A
MONTHLY BASIS.
PREPRINT SHARING OVERALL IS
ABSOLUTELY NOWHERE CLOSE TO
REPLACING THE ARTICLE AS THEPRIMARY MEANS FOR SCIENCE.
ESTIMATES PUT THE NUMBER OF
PREPRINTS POSTED MONTHLY TO BE
3% OF THE VOLUME OF RECORDS
ADDED TO PUBMED DURING THE SAME
TIME PERIOD.
LET'S SPEND A FEW MINUTES TRYING
TO UNDERSTAND THAT LITTLE SLIVER
OF THE 3% THERE.
FIRST STARTERS, WHY WOULD A
RESEARCHER POST A PREPRINT?
A SURVEY COMPLETE BIORXIV FOUND
RESEARCHERS ARE MAINLY MOTIVATED
TO ENSURE THE QUALITY IMPACT AND
DISCOVERABILITY OF THE RESEARCH.
PREPRINT POSTING IS ALTRUIST IN SOME WAYS.
IT AIMS TO BENEFIT SCIENCE BUT
COMES WITH A NUMBER OF
PERCEIVED BENEFITS TO THE
INDIVIDUAL RESEARCHERS FOCUSSED
ON INCREASING THE AWARENTHE RESEARCH STAKING A PRIORITY
CLAIM AND HAVING CONTROL WHEN
THE RESEARCH IS MADE AVAILABLE.
THE SAME BIO ARCHIVE SURVEY
FOUND 37% OF PREPRINTS ARE
ED PRIOR TO SUBMITTING TO
THE AUTHOR'S FIRST CHOICE
JOURNAL WHERE THE OPPORTUNITY
FOR EARLY FEEDBACK TO THE RIGOR AND REPRODUCIBILITY OF
THE RESEARCH SEEMS TO COME IN.
42% ARE POST AT THE TIME OF
SUBMISSION TO THE AUTHORS.
FIRST CHOICE JOURNAL AND I THINK
OF THOSE AS THE FOLKS WHO CARE ABOUT HAVING CONTROL OVER WHEN
THE PAPER IS MADE AVAILABLE.
THERE'S ALSO THIS OTHER 21%
WHICH IS A BIT FUZZIER WHETHTHEY'RE POSTING EARLY RESULTS OR
CONTENT WHICINTEND TO SUBMIT FOR PUBLICATION
EITHER BECAUSE IT'S A
REPLICATION STUDY OR NEGATIVE
RESULT DON'T FAREWELL WITH
JOURNAL SELECTION PROCESSES OR
BECAUSE IT'S VERY PRELIMINARY.
WHAT WE CAN GLEAN FROM THIS IS
THE TIMING OF THE POSTING COME
DOWN TO SORT OF WHAT THE
AUTHOR'S MOTIVATIONS ARE AND
THOSE WILL HAVE A SPEED ON HOW
EARLY THE PAPER'S DISSEMINATED.
SO THEN LOOKJOURNAL PEER REVIEW PROCESS CAN
AFFECT DISSEMINATION SPEED AND THE BENEFITS OF POST PREPRINT
ARE AND THIS COULD BE HARD TO
QUAN THERE MAY BE MORE CURRENT
STUDIES WITH RESEARCH SQUARE AND
OTHERS WILL HAVE MORE OF THE
DATA SOON BUT RIGHT NOW I HAVE
BEEN USING A 2015 ANALYSIS
PUBLISHED IN NATURE AND THE
STUDY FOUND PAPERS IN PU WITH TRANSPARENT SUBMISSION,
ACCEPTANCE DATES FOR THOSE THE
MEDIAN TIME FOR ACCEPTANCE WAS
AROUND 100 DAYS.
THIS COMES WITH A NUMBER OF
CAVEATS, ACCEPTANCPUBLICATION AND SUBMISSION DATA
ARE NOT ALWAYS ACCESSIBLE SO
IT'S COMING FROM A SMALL SUBSET
AND ASSUMES THE JOURNAL IN
QUESTION WAS THE FIRST JOURNAL
THE AUTHOR SUBMITTED TO
REJECTION AT ONE JOURNAL COULD
ADD FURTHER DELAYS BETWEEN A
PREPRINT AND PUBLISHER VERSION
BEING AVAILABLE.
LOOKING SPECIFICALLY AT
BIOARCHIVE CONTENT BECAUSE THEY
HAVE MORE DATA, COLD SPRING
HARBOR LAB WHICH OPERATES THE
PLATFORM ESTIMATED IN 2019, 70%
OF BIO ARCHIVE ARE PUBLISHED AND
POST TO JOURNAL PUBLICATION SIX TO SEVEN MONTHS ON AVERAGE.
LOOKING AT HOW PEOPLE ARE
EXPERIMENTING WITH INCREASING
VISIBILITY AND DISSEMINATION OF
THE PREPRINTS TO MAKE UP FOR THE
GAP BETWEEN PREPRINT POSTING AND
PEER REVIEW.
I MENTIONED HOW SPRINGER NATURE
IS TEAMING UP WITH RESEARCH
SQUARE TO MAKE SURE THE PEERREVIEW STATS WITH PREPRINTS WITH
THEIR TITLES IS AVAILABLE AND
OPT-IN SERVICE AND THERE'S A
GROUP CALLED PRELIGHTS WHICH SAY
HIGHLIGHT SERVICE RUN BY T COMPANY OF BIOLOGIST TO HELP
RESEARCHERS FIND AND FILTER
RELEVANT PREPRINTS BY SELECTING
AND HIGHLIGHTING AND COMMENTING
ON THOSE THEY FEEL ARE OF
PARTICULAR INTEREST TO T COMMUNITY.
AND THEN THERE IS THIS IDEA OF OVERLAY PUBLISHING OR LAYERING
JOURNALS ON TOP OF PREPRINT
SERVER PLATFORMS.
THE IDEA WITH THE JOURNALS IS
THEY'LL PROVIDE PEER-REVIEW BUT
THE ARTICLES REMAIN ON THE
SERVER.
THE ACCEPTED MANUSCRIPT VERSION
IS POSTED AS A VERSION OF THE
PREPRINT ON THE PREPRINT SERVER
ITSELF AND GIVEN A DOI BY THE
OVERLAY JOURNAL THAT CERTIFIES
AS THE PUBLISHER VERSION.
AND WHILE THESE ARE INTERESTING
AND MAYBE VARYING LEVELS OF
COMPLICATION, I THIN REFLECT THE CREATIVE THINKING
HAPPENING AROUND HOW PREPRINTS
COULD BE MADE MORE VISIBLE AND
DISSEMINATED AND INCREASE THE
TRANSPARENCY OF THE PROCESS
THROUGH PREPRINTS.
WITH ALL THE PERCEIVED BENEFITS
AND EXPERIMENTATION AND
OPPORTUNITIES HERE WHAT ARE THE
DETERRENTS?
A VERY FEW OF THE BIO ARCHIVE
REPORT NOT HAVING BEEN
NEGATIVELY IMPACTED BUT 6% SAID
THEIR CHOICE OF JOURNAL FOR
PUBLICATION AND SOMETHING
RESEARCHERS NEED TO BE MADE
AWARE OF UP FRONT AS FAR AS
PREPRINT EDUCATION ONCE IT'S
MADE PUBLIC IT'S PART OF A
SCHOLARLY RECORD AND CITABLE AND
CAN'T DISAPPEAR.
KNOWING THE PRE PRINT THEY INTEND TO SUBMIT TO IS
CRITICAL.
ONE TOOL AT THEIR DISPOSAL IS
THIS ONE YOU SEE HERE CALLED
S POSE.
IT'S A DATABASE OF VARIO POLICIES.
IT PULLS TOGETHER LINK AND INFORMATION ON A JOURNAL'S
POLICIES ON POSTING PRE PRINTS
AND CITING PREPRINTS AND CITING
AND MEDIA COVERAGE AND SO MUIS AVAILABLE.
NOT ALL JOURNALS HAVE THESE
POLICIES BUT THIS IS A FAIRLY
CENTRALIZED SOURCE TO LOOK FOR
THEM.
IT'S ALSO WORTH NOTING WHEN NIH
DID A REQUEST FOR INFORMATION IN
2016 ON SHARING PREPRINTS, SOME
OF THE RESPONDENTS NOTED SPECIAL
RISK FOR THE GEN CLINICIANS, PATIENTS AND MEDIA
IN ACCEPTING PRODUCT HAVE NOT
BEEN PEER-REVIEWED BUT TGREAT FOR CLINICAL RESEARCH AND
ONE OF THE REASONS IF YOU'RE
FAMILIAR WITH META-ARCHIVE
THEY'RE MORE OF A SCREENING IN
CONJUNCTION WITH
BMJ AND YALE TO SORT OF COVER
THEMSELVES.
SIMILARLY A GROUP CALLED
KNOWLEDGE EXCHANGE COMPLETED A
STUDY LAST YEAR THAT IN PART
LOOKED AT THE BENEFITS TO
RESEARCHERS AS WELL AS T DISINCENTIVES AROUND PREPRINTS
AND FOUND SIMILAR CONCERNS
AROUND QUALITY INSURANCE, RISK
OF HARM AND MEDIA REPORTING
INCORRECT THOUGH MOST SE COMFORTABLE WITH MITIGATING
THESE RISKS.
I THINK IT CAN BE SAID THOUGH
THE CONCERNS EXIST ACROSS THE
LIFE SPAN.
THIS IS FROM A COMMENT PUBLISHED
IN THE LANCET IN DEPUTY DIRECTOR FOR EXTRAMURAL
RESEARCH AT NIH.
PREPRINTS ARE VERY MUCH AN AREA
OF INTEREST FOR OUR OFFICE OF
EXTRAMURAL RESEARCH.
IT'S PARTLY WHY WE'RE DOING THIS
TODAY.
I THOUGHT IT WOULD BE
INTERESTING IF WE COULD GET A
BASELINE UNDERSTANDING OF HOW
MANY OF YOU SUPPORT NIH
RESEARCHERS AT YOUR INSTITUTION.
I'VE NEVER DONE THIS BEFORE BUT
I'M TOLD IF YOU USE THE GREEN
CHECK BOX OR THE RED X WE CAN
POLL YOU GUYS.
SO IF YOU CAN CHECK THE GREEN TO
INDICATE YESSUPPORTED RESEARCHERS OR THE RED
TO INDICATE YOU DON'T THAT WOULD
BE INTERESTING FOR US TO KNOW.
BACK TO WHAT THE DOCTOR WAS
WRITING HIS CO-AUTHORS WROTE NOT
DISMISSING FOR CLINICIANS TO BE
UNCERTAIN HOW TO INCORPORATE THE
LITERATURE BUT THAT WITHOUT THE
BENEFIT OF SYSREVIEW AND CLINICIANS, PATIENTS
AND THE PUBLIC WILL NOT KNOW HOW
TO BEST INTERPRET ANY PARTICULAR
STUDY'S FINDING UNLIKELY TO BE THE FINAL WORD ON
THE MATTER CONTINUING POPUBLICATION DIALOGUE IS PART AND
PARCEL OF KNOWLEDGE ACQUISITION.
THIS CAPTURES HOW I ULTIMATELY
LIKE TO VIEW PREPRINT.
THEY REFLECT SCIENCE IS AN
GOING DIALOGUE OF DISCOVERY
AND HAVE THE POTENTIAL TO PLAY A
KEY ROLE IN HOW THE CONVERSATION
CAN BE MADE MORE OPEN AND
TRANSPARENT AND HOPEFULLY MORERIGOROUS AND PRODUCTIVE.
THIS POTENTIAL ALSO LIES BEHIND
SOME IDEAS TO NIH ISSUING A
GUIDE NOTICE IN 2017 ENCOURAGING
INVESTIGATORS RESEARCH PRODUCTS SUCH AS
PREPRINTS TO DISSEMINATION AND ENHANCE THE
RIGOR OF THEIR WORK.
THIS NOTICE CLARIFIED REPORTING
INSTRUCTION TOINVESTIGATORS CITE PREPRINTS AND
CLAIM THEM AS FUNDPROGRESS REPORT.
AS NIH'S AIM IS TO MAXIMIZE THE
PREPRINTS THE GUIDELINES
INED REAL EXPECTATIONS THAT
ENSURING A HIGH LEVEL OF ACCESS
TO THE PRODUCTS MAY MAKE SURE
THEY'RE POSTED TO OPEN AAVAILABLE REPOSITORIES AND TEXT
MINING FOR THE ANALY PRODUCTS AND THE NIH EXPECTS
AUTHORS TO AUTHORIZE TERMS OF
USE SUCH AS A CREATIVE COMMONSLICENSE OR DEDICATE THE WORK TO
THE PUBLIC DOMAIN.
NIH ALSO EXPECTS AWARDEES THATST PREPRINTS WILL ADHERE TO
THE OTHER NORMS OF RESPONS SCIENTIFIC COMMUNICATION THEY
WILL ACKNOWLEDGE NIH SUPPORT AND
CLEARLY STATE PEER-REVIEWED AND DECLARE ANY
COMPETING INTEREST.
SAME FOR A JOURNAL ARTICLE.
IN CITING A PREPRINT THEY WILLCITE THE PRE PRINT AND UPDATE IT
AND THE VERSION AND THE DAY THE
PRODUCT WAS CITED.
THESE REQUIREMENTS ARE INTENDED
TO HELP THE REVIEWER UNDERSTAND
THE PRODUCT IS PUBLIC AND
INTERIM AND IDENTIFY WHICH
VERSION IS BEING REFERENCED.
AS THE PREPRINTS IS GROWING
RAPIDLY AND IN MANY SCDIRECTIONS THE NORMS AND
STANDARDS FOR THE PLATFORMS ARE
STILL EVOLVING.
TO ENSURE PRACTICES FOR
PREPRINTS FACILITATE THE IMPACT
MEASUREMENT AND INTEGRITY OF THE
SCIENTIFIC RECORD, NIH STRONGLY
ENCOURAGED PART OF THE NOTICE
THAT AWA REPOSITORIES THAT MAKE THE
CONTENT FINDABLE, ACCESSIBLE AND
INTEROPERABLE AND REUSABLE WHICH
CAN BE A CHALLENGE ESPECIALLY ON
THE INTEROPERABLE PIECE ANVE TRANSPARENT POLICIES ABOUT
PLAGIARISM, COMPETING INTEREST
AND CONDUCT AND MAINTAIN A
RECORD OF CHANGES OR VERSIONS OF
THE PREPRINT AND LINK TO THE PUBLISHED VERSION WHEN
AVAILABLE.
IT'S ALSO AN EXPECTATION THAT
THE PREPRINTS HAVE A ROBUST
ARCHIVING STRATEGY THAT ENSURES
PRESERVATION AND ACCESS.
THIS IS A NEW AREA FOR A LOT OF
FOLKS AND SO WE SEE VARYING
LEVELS OF ARCHIVAL OR
PRESERVATION STRATEGIES ACROSS PREPRINT SERVERS.
THAT'S A VERY QUICK AND DIRTY
RUN THROUGH OF THE NIH GUIDANCE
AROUND PREPRINTS.
IT'S NEVER BEEN QUITE CLEAR TO
ELL THAT MESSAGE REALLY
PERMEATED IN 2017 AND WE'LL GET
INTO WHY I HAVE QUESTIONS ABOUT
THAT SHORTLY.
IF WE CAN DO ONE MORE POLL, IF
YOU ARE FAMILIAR WITH THE NIH
GUIDANCE, GREEN CHECK MARK AIF IT WAS NEW TO YOU OR AT LEAST
THAT LEVEL OF DETAIL WAS NEW TO
YOU, THE RED X WOULD BE GREAT.
THAT SHOULD HELP US INFORM SOME
OF OUR FUTURE COMMUNICATION
EFFORTS.
NOT ONLY HAS THIS BEEN SOMETHING
WE HAD THE GUIDE NOTICE ABOUT
BUT TWO MAJOR RESEARCHINITIATIVES AT NIH HAVE ADOPTED
PUBLICATION AND DATA SHARI POLICIES THAT ENCAPSULATE
PREPRINTS AND THEIR DEFINITION
OF A PUBLICATION EMPHASIZING THE
RAPID AVAILABILITY OF
PUBLICATIONS PRE PRO DISSEMINATION OF KNOWLEDGE AND
BUILDS ON NEW DISCOVERIES.
FOR THE HEAL INITIATIVE AND THE
CANCER MOONSHOT WHERE THE
AMBITIOUS GOAL OF CURING CANCERS
THESE ARE THE TWO AREAS THEY
TO SEE QUICK RESULTS AND
PREPRINTS ARE AN OPPORTUNITY IN
THEIR VIEW TO ACCELERATE THAT
SORT OF RESEARCH.
RECOGNIZING FOR ALL OF T REASONS NIH IS VERY INTERESTED
IN PREPRINTS.
IN DECEMBER 2019 WE PULLED DATA
ON THE NUMBER OF PREPRINT HAVEBEEN ASSOCIATED WITH NIH AWARDS
SINCE THE EFFECTIVE DATE OF 2017
GUIDE NOTICE.
I SUSPECT MANY OF YOU KNOW
MATELY MY BIBLIOGRAPHY IS
USED BY THE AWARDS OR ON BEHALF
OF INVESTIGATORS TO BUILD
PROGRESS REPORT PUBLICATION
LISTS.
THIS TOOL SEEMS LIKE ONE CHANNEL
TO HELP US BEGIN UNDERSTANDINGTHE IMPACT OF THE 2017 NOTICE ON
NIH RESEARCHER PRACTICES.
WHAT WE FOUND IS AROUND 500
PREPRINT RECORDS HAVE BEEN
ASSOCIATED WITH NIH AWARDS IN
THE 30 MONTHS OR SO AND THE VAST
MAJORITY OF WHICH WERE POSTED TO
THE PREPRINT SERVER BIO ARCHIVE.
TO PUT THE NUMBERS INTO SOME
CONTEXT DURING THE SAME PERIOD
MORE THAN 200,000 PEER-REVIEWED
PAPERS WERE DEPOSITED IN
COMPLIANCE WITH THE PUBLIC
ACCESS POLICY.
WE'RE LOOKING AT LESS THAN 1% OF
PAPERS WITH NIH SUPPORT AT THAT
TIME WERE PROBABLY AVAILABLE IN
PREPRINT.
SOME WILL COME DOWN TO THE FACT
THAT MANY WERE NOT REPORTED AND
IT'S NOT CLEAR TO ME WHETHER
ONCE THERE SAY PUBLISHED VERSION
IF AUTHORS GO BACK AND REMOVE
PREPRINTS FROM THEIR
BIBLIOGRAPHY I HAVE TO ASSUME
IT'S NOT IN THE REALM OF
THOUSAND MAYBE A FEW HUNDRED
UNDERREPORTING.
WE ALSO TOOK THE SUBSET PREPRINTS REPORTED IN MY
BIBLIOGRAPHY AND PULLED THE
LICENSE METADATA FOR EAC THOSE AND WE FOUND ROUGHLY
ONE-THIRD OF THE PREPRINTS WITH
NIH SUPPORT WE WERWERE NOT AVAILABLE UNDER
CREATIVE COMMONS LICENSE OR IN
THE PUBLIC DOMAIN DESPITE NIH'S
GUIDANCE ON THIS.
SO LOOKING INTO THE DATA WE
FOUND THAT YES, NIH RESEARCHERS
WERE POSTING PRESOMETIMES, MAYBE, BUT AT A LOWER
RATE THAN PERHAPS NIH WOULD LIKE
TO SEE AND EVEN WHERE THE PREPRINTS WERE BEING
POSTED, THE LICENSE TERMS UNDER
WHICH THEY WERE BEING MADE
AVAILABLE WASN'T ALWAYS IN LINE
WITH NIH RECOMMENDATIONS.
SO LOOKING AT THE PREPRINTAPE CLOSE TO HOME, WE WERE
SEEING THE GLARING GAP BETWETHE PRACTICE AND GUIDANCE AMONG
PREPRINTS WITH NIH R AT THE SAME TIME THERE WERE
QUESTIONS ABOUT THE ROLE OF
DISCOVERY AND MAXIMIZING THE
CT OF NIH RESEARCH RESULT
WHICH IS IS WHERE NLM CAME IN.
IT WAS REALLY TO THIS IDEA OF
DISCOVERY AND IMPACT THAT NLM
BEGAN CONSIDERING A PILOT
PROJECT WE ARE NOW CALLING THE
PREPRINT PILOT TO TEST THE
VIABILITY OF MAKING PREPRINTS
FROM THE RESULT OF NIH-FUNDED
RESEARCH AVAILABLE BY A PMC AS
PART OF OUR FULL TEXT DIGITAL
ARCHIVE WITH THE IDEA THE
LESSONS LEARN COULD INFORM FUTURE EFFORTS
AROUND PREPRINTS.
THE NIH PREPRINT PILOT IS
INTENDED TO BE A L TO ADD PREPRINTS WITH NIH
SUPPORT.
AND POSTED TO ELIGIBLE SERVERS
TO PMC.
WE ANTICIPATE DOING THIS WORK BY
AUTOMATED POLLS OF CONTENT BY
PREPRINT SERVERS AND LEVERAGING
OUR WORK FLOWS TO ADD THAT TO
PMC IN A WAY THAT ADDITIONAL BURDEN OR EFFORT FOR
THE AUTHOR BEYOND ESTABLISHED
NIH GUIDANCE.
FOR A PREPRINT TO BE ADDED TO
PMC AS PART OF THE PILOT, IT WILL NEED TO CLEARLY INDICATE
NIH SUPPORT EITHER THE WARD
ITSELF OR HAVE THE AFFILIATED
AUTHOR AND MUST BE POSTED EPRINT SERVER THAT IS INCLUDED
IN THE PILOT AND WILL HAVE A
CREATIVE COMMONS LICENSE THAT
ALLOWS FOR FULIN PMC.
WE WANT TO ENSURE WE'RE
EXPANDING THE DISCOVERY OF PREPRINTS THAT DON'T HAVE
CREATIVE COMMONSWELL BUT HAVE STILL WORKING OUT
THE WORK FLOWS.
WE'RE LOOKING AT THOSE AND WE'LL
FIGURE OUT WHAT TO DO REST.
WE ANTICIPATE LAUNCHING THE
PILOT WAY FOCUS ON WHERENIH-FUNDED PREPRINTS ARE
PREDOMINANTLY BEING POSTED AS
FAR AS THE PREPRINT SERVERS
WE'LL BE WORKING WITH AND TH MEANS LARGELY BIO ARCHIVES AND
WE'RE SEEING META-ARCHIVE NOW
THAT AROUND AND THERE'S
NIH-FUNDED PAPER IN CHEM ARCHIVE
AND RESEARCH SQUARE.
WE FORESEE THE LIST EXPAND
AGENCIES WE HAVE MORE ROBUST
WORK FLOWS BUT SINCE IT'S A
PILOT WE DON'T WANT TO TRY TO DO
EVERYTHING QUITE YET.
IN ORDER TO BE CONSIDERED IN
INCLUSION IN ADDITION TO HAVING
SUFFICIENT PAPERS WITH NIH
SUPPORT WE HAVE GENERAL
EXPECTATIONS OF TRANSPARENCY.
THESE ARE SORT OF MEANT TO ALIGN
WITH THE NIH GUIDANCE WE TALKED
THROUGH EARLIER.
WELL BE LOOKING TO SEE THEY
DEMONSTRATE TR POLICIES AND PRACTICES MEANING
THEY CLEARLY INDICATE THE PEER
REVIEW STATUS AND LICENSE AND
HAVE A TRANSPARENT SCR PROCESS AND RIGOROUS POLICIES
ABOUT PLAGIARISM AND COMPE ARE AND CONDUCT AND THEY'LL
ADHERE TO SCHOLARLY PUBLISHINGPRACTICES AND MAINTENANCE OF THE
RECORD AND WITHDRAW POLICIES FOR
THE REMOVAL OF A PREPRINT AND AN
ARCHIVING STRATEGY.
FURTHER IN LINE WITH NIH
CE AND TO SUPPORT OUR OWN
WORK FLOWS TO MAKE IT WORK AT
MINIMAL COST TO AUTHORS,LL CONSIDER WHETHER THE SERVER
MAKES A CREATIVE COMMONS OPTION
AVAILABLE AND WHETHER WE CANGRAB THE METADATA AND FILES IN A
AN API OR MACHINE-READABLE WAY
AND TAKE INTO ACCOUNT THE SERVER
AND SCOPE AND CONTENT TYPE.
THERE'S A NUMBER OF REPOSITORIES
THAT DON'T ACCEPT JUST PREPRINTS
AND I THINK FOR THE SCOPE OF THE
PILOT WE'LL BE FOCUSSING ON THE
ONES THAT HAVE PREPRINSPECIFIC SCOPES.
IT'S JUST A BIT CLEANER FOR POLICY WISE TO UNDERSTAND THEIR
WORK FLOWS.
AND TO CURATE THE CONTENT.
I ALSO WANT TO TAKE THIS
OPPORTUNITY TO BE VERY EXPLICIT
OF WHAT IT IS NOT BEFORE IT
COMES BACK TO HAUNT ME ON SOCIAL
MEDIA.
THEY'RE NOT BUILD PREPRINT
SERVER FOR INVESTIGATORS AND NIH
IS NOT BUILD DISCOVERY RESOURCE.
WE ARE ONLY SELECTING
NIH-SUPPORTED PREPRINTS AND FOR
SOME PEOPLE THISRELIEF.
FOR OTHERS IT WILL BE A
DISAPPOINTMENT.
OUR THINKING IS WE WANT TO BE
ABLE TO LEVERAGE EXISTING
QUALITY ASSURANCE MECHANISMS THAT NIH HAS IN PLACE AROUND
PEER REVIEW OF GRANTS AS WELL AS
INTERNAL MANUSCRIPT PROCESSES TO
COVER US ON THAT QUALITY
ASSURANCE SIDE OF THINGS WHILE
WE GET A BETTER UNDERSTANDING OF
THE LANDSCAPE.
WE'RE WANTING TO MAKE SURE
THERE'S IN THE A NEW
REQUIREMENT.
PREPRINT POSTING IS OPTIONJUST WANT TO MAKE IT EASIER AS
PART OF THE PILOT FOR
RESEARCHERS TO CITE THOSE ON THEIR PROGRESS REPORTS AND BE
INCENTIVIZED BY THE
DISCOVERABILITY ANGLE TO FOLLOW
THROUGH WITH POSTING.
WE'RE HOPING WE CAN BUILD PMC'S ROLE AS A CENTRAL ARCHIVE
OF RESEARCH SUPPORT NIH ENCOURAGE THE OPEN AND FAST
DISSEMINATION OF RESEARCH
RESULTS WHEN APPROPRIATE.
BECAUSE IT'S A NEWWE'LL TAKE A PHASED APPROACH TO
THE PILOT IMPLEMENTATION.
IN THE FIRST PHASE WE'RE HOPING
TO LAUNCH LATER THIS MONTH
KNOWING THE LAST DAY OF THE
MONTH WE'LL BE INGEST ING
COVID-19 RELATED PREPRINTS WITH
NIH SUPPORT AND WE ARE TRYING TO
RESPOND TO THE NEEDS OF THE
COMMUNITY TO BRING TOGETHER MORE
LITERATURE ON THE TOPIC IN ONE PLACE.
WE ALREADY HAVE A SIGNIFICANT
AMOUNT OF CORONAVIRUS AND
COVID-19 CONTENT IN PMC AND
HOPING THIS CAN ADD TO THAT AND
WE'RE ALSO HOPING TO LEVERAGE
SOME OF THE EXISTING TOOLS THAT
ARE OUT THERE LIKE THE OFFICE OF PORTFOLIO ANALYSIS
COVID-19 PORTFOLIO TO SUPPORT
OUR WORK FLOWS.
WE'RE USING A FAIRLY MANUAL WORK
FLOW FOR THE FIRST PHASE AS FAR
AS IDENTIFYING AND CURATING NIH
SUPPORTED PREPRINTS.
THERE'S UNFORTUNATELY NOT A LOT
OF AUTOMATED WAYS TO DO THIS BUT
IF YOU KNOW OF ONE E-MAIL ME.
ONCE WE GET IT UP AND RUNNING
SMOOTHLY WE PLAN TO RAMP UP THE
WORK FLOWS AND EXPAND OUR
PREPRINT SERVER ENGAGEME ACCORDINGLY AS NEEDED.
WHEN WE DO SO, WE'LL LIKELY RELYING MORE ON MINING THE TEXT
FOR FUNDING DATA.
WE'RE ABLE TO DO THIS WITH BARCHIVE WHICH MADE XML AVAILABLE
AND WE'LL ALSO BE RELYING ON
FUNDING DATA AND AUTHOR
AFFILIATION METADATA BE
AVAILABLE WITH PREPRINT WHICH IS
NOT ALWAYS THE CASE.
TO THAT END, WE HAVE CONCURRENT THIRD PHASE WE HOPE
TO HAVE READY TO SIMPLIFY THE
REPORTING OF PREPRINTS IN MY BIBLIOGRAPHY AND NO LONGER ASK
THEM TO QUALIFY THE RESEARCH
PRODUCTS I DON'T THINK THAT
PHRASE CAUGHT ON AND WILL A LOW
THEM TO SUPPORT AWARD
APPRECIATIONS AND CURATION
ESSES.
WE'RE ALSO HOPING TO USING EXTRAMURAL COMMUNICATIONS FOR
THE EFFORT AFTER A MINIMUM OF 12
MONTHS BECAUSE WE WANT TO HASUFFICIENT DATA TO BE AVAILABLE
SO IT MAY GO A LITTLE LONGER
G ON SORT OF THE UPTAKE,
WE'LL COMPLETE AN EVALUATION OF
THE PILOT TO INFORM FUTURE EFFORTS AND WHAT MAYBE ISN'T
CAPTURED HERE IS THAT THROUGHOUT
ALL THESE PHASES WE HOPE TO BE ENGAGING STAKEHOLDERS AND
COLLECTING FEEDBACK ON HOW TO
BEST MANAGE THE BENEFITS AND
CHALLENGES PRESENTED BY
PREPRINTS.
THIS IS WHAT IT WILL LOOK LIKE A
CORRESPONDING RECORD THA FOLLOW A SIMILAR PRESENTATION.
THE IDEA IS TO USE THE SAME SORT
OF EXPECTATIONS OF TRANSPARENCY
WE'RE APPLYING TO SERVERS OURSELVES.
WE'LL BE CLEARLY INDICATING THIS
SAY PREPRINT IN MANY PLACES, THE
BANNER, THE CITATION ALONG THE
SIDE.
WE'RE GOING TO INCLUDE LINKS TO
THE PEER-REVIEWED ARTICLE WHEN
AVAILABLE AND INCLUDE LINK TO
THE PREPRINT SERVER AND AL SURE WE ARE BEING EXPLICIT
AND IT HAS NOT BEEN
PEER-REVIEWED AND LINK TO INFORMATIONAL PAGE ON THE
PREPRINT PILOT WE HOPE TO
PROVIDE CONTEXT FOR THE PILOT
AND EDUCATIONAL MATERI PREPRINTS.
WE ALSO BE SETTING UP FILTERS SO
FOLKS CAN SEARCH ONLY PREPRINTS
OR JUST FILTER OUT PREPRINTS IF
THEY'RE MAINLY CONCERNED WITH
FINDING THE PEER-REVIEWED
LITERATU OUR LITERATURE GENE HAS BEENACTIVELY WORKING WITH THE OFFICE
OF STRATEGIC INITIATIVE TO
THE EXPECTS OUTCOME AND
OUTCOME MEASURES FOR THE WORK.
I TEND TO LUMP THEM INTO T GROUPS IN MY HEAD AT LEAST.
THE FIRST IS THE GOAL OF
INCREASING DISCOVERY OF
PREPRINTS WHICH HAS SHAPED OURDECISION MAKING AROUND THE PILOT
AND TO EVALUATE THE SUCCESS AND
IMPACT AT THE MOST BASIC LEVEL
WHAT WE'LL BE WANTING TO SEE IS
THE PREPRINTS ARE DISCOVERAND ACCESSED AND LOOKING AT FULL
TEXT VIEWS AT PMC AND THE CLICK
THROUGH RATES FOR THE SERVERS
AND WANT TO BE ABLE TO DEMONSTRATE WE'RE ENABLING
FASTER DISSEMINATION OF
NIH-SUPPORTED RESEARCH.
SOME OF THIS IS GOING TO COME
DOWN TO WHETHER WE CAN SET UP
WORK FLOWS THAT IDPREPRINTS EARLY ENOUGH TO REALLY
SEE A BENEFIT.
WE'RE ALSO INTERESTED IN TIDEA BY INCREASING DISCOVERY OF
PREPRINTS, IT MAY LEAD TO A
WIDER ADOPTION O POSTING BY NIH RESEARCHERS AND
OTHERS.
WE'LL BE LOOKING AT WAYS TO
MEASURE THAT TYPE OF GROWTH ASWELL AND SEEING WHETHER
INDEXING, ARCHIVING AND
DISCOVERY IS AN INCENTIVE FOR
SOME.
THE PREPRINT PILOT IS ALSO
CONSISTENT WITH CURRENT NLM
STRATEGIC GOALS COMMITTED IN ITS STRATEGIC PLAN
TO ANTICIPATE DEVELOPMENT SUCH AS PREPRINTS AND NOVEL
ALTERNATIVES AS A MODE TO
ACCELERATE DISCOVERY AND ADVANCE
HEALTH.
IT'S AN EXCITING OPPORTUNITY FOR
US AS A LIBRARY AND REPOSITORY.
THAT BEING SAID, WE DO HAVE SOME
OUTCOME MEASURES THAT ARE FOR
OURSELVES AND THE THOSE IS TO MAKE SURE THAT WE
CAN MAINTAIN CONTINUED TRUST ON
NLM RESOURCE.
WE'LL BE CAREFULLY MONITORING
WHAT FEEDBACK WE RECEIVE,
E-MAIL, SOCIAL MEDIA OR WORD OF
MOUTH AND HOPE THAT ENGAGEMENT
CAN HELP US UNDERSTAND THE NEEDS
OF DIFFERENT GROUPS AND RESPOND
TO THEM PROACTIVELY.
WE'RE ALSO HOPING TO CULTIVATE A
GREATER AWARENESS AND
UNDERSTANDING OF PREPRINTS.
THIS DOESN'T JUST MEAN PEOPLE
UNDERSTAND A PREPRINT IS NOT
PEER REVIEWED, THAT'S A GOOD
START BUT WANT TO SEE THE NEEDLE
MOVE AS FAR AS RESEARCHER
PRACTICES AROUND POSTING
PREPRINTS AND WHAT LICENSES THEY
CHOOSE, HOW THEY REPORT THEM AND
OVERALL INCREASED COMP WITH THE GUIDANCE THAT NIH
ISSUED.
FINALLY, WE'D LOVE TO SEE A
COALESCENCE AROUND BEST
PRACTICES FOR PREPRINTS.
WE'VE COME TO APPRECIATE IN PMC
THE BEST PRACTICES AND WOULD LIKE TO SEE SOMETHING SIMILAR
EMERGE FOR PREPRINT TO HAVE A
SAME BASELINE TO WORK FROM A WE'RE LOOKING AT METADATA
STANDARDS AS WELL AS POLICY
STANDARDS WHILE STILL KEEPING
ROOM FOR DIFFERENT MODELS AND
CONTINUED EXPERIMENTATION.
WE'RE LOOKING FOR WAYS TO MAKE
SURE THAT WE RECOGNIZE THESE
ARTICLES ARE PART OF THE
SCHOLARLY DIALOGUE AND MAKE SURE
THEY ARE PRESERVED AND MADE
AVAILABLE AS SUCH.
WE DO ANTICIPATE A NUMBECHALLENGE WILL COME UP.
I'VE ALREADY MENTIONED WHAT I'M
EXPECTED TO DEAL WITH AS FAR AS
CURATION IF YOU DON'T HA SCALEABILITY AROUND COVID WE
WILL BE RELYING ON
[INDISCERNIBLE] THAT DOESN'T
CURRENTLY EXIST AND FOR THE NLM
TO ACHIEVE THOSE OUTCOMES, THERE
NEEDS TO BE A GREATER AWARENESS
OF PREPRINTS ANDENGAGEMENT BECAUSE TRUE SUCCESS
IS GOING TO BE DEPENDENT ON A
CULTURE CHANGE AND HOW THEY
COMMUNICATE RESEARCH RESULTS.
AND IT'S REALLY AROUND T SORT OF IDEAS OF AWARENESS AND
TRUST AND EDUCATION THAT I FEEL
LIKE THERE LIE OPPORTUNITIES FOR
NLM AND NNLM TO BRING ABOUT
CHANGE.
AS WE SEE SCIENCE BECOME MORE
REAL TIME AROUND THE PANDEMIC
AND HOPEFULLY OTHER RESEARCH AREAS AS WELL, WE HAVE AN
OPPORTUNITY TO BE ADVOCATES FOR
OPENNESS AND TRANSPARENCY AND
PROVIDE EXPERTISE AND EDUCATION
TO ENSURE THE OPENNESS,
TRANSPARENCY AND SPEED DON'T
COME AT WITH LESS QUALITY AND I
SAW A WEBINAR I WAS ATTENDING ON
DATA SHARING LAST WEEK AND IT
STRUCK ME HOW IMPORTANT IT WTO PREPRINT SHARING AS WELL.
AS THE NUMBERS WE'VE SEEN
THROUGHOUT THE PRESENTATION HAVE
SHOWN, WE'RE STILL VERY MUCH IN
THE EARLY DAYS AND I D CONSIDER MYSELF ENOUGH OF A
STATISTICIAN TO TELL YOU WHETHER
WE'RE INNOVATORS OR EARLY
ADOPTERS BUT THE QUESTION IS HOW
TO PUSH THINGS TOWARDS AN EARLY
MAJORITY AND THAT'S WHERE WE SEE
AN OPPORTUNITY FOR OURSELVES AND
NLM AND PROBABLY WITHIN YOUR LIBRARIES AS WELL.
ACCORDING TO THIS DIFFUSION OF
INTEGRATION MODEL THE EARLY
MAJORITY IS HOLDING BACK A BIT LONGER WHEN A KNEW IDEA IS
PRESENTED TO SEE IF IT WORKS OUT
FOR THE EARLY ADOPTERS.
THEY WANT TO KNOW THE OBSTACLES
AND HURDLES ARE AND IF THEBEEN OVERCOME AND THE MERITS AND
HOW THEY'RE ADDRESSED AND
COMMUNICATED IN THE NEXT 12
MONTHS I THINK WILL BE KEY IN
THE SUCCESS AND IN BRINGING
AROUND CULTURE CHANGE AROUND
LTURE CHANGE IN THE BIO
MEDICAL AND LIFE SCIENCES.
THE QUESTIONS OF THE EARLY MAJORITY INDICATE A POTENTIAL
NEED FOR THE EDUCATION AND AWARENESS RAISING REGARDING
PREPRINT SERVERS, JOURNAL
POLICIES, FUNDER POL NAVIGATING LICENSES AS WELL AS
THE HURDLES THEY NEED TO BE
AWARE OF TO PREVENT PROBLEMSDOWN THE STREAM.
I CAN'T THINK OF ANYONE THAN LIBRARIANS WHO ARE ALREADY
EMBEDDED IN THE RESEARCH SUPPORT
ECO SYSTEM TO TAKE THIS ON.
THERE ARE RESOURCES AND POLICIES
ON POLICIES AND LICENSING.
I MENTION THE TRANSPOSE.
THERE'S ALSO A TOOL ON HELPING
RESEARCHERS SELECT LICENSES FOR
PREPRINTS OUT THERE.
BUT BRINGING THOSEAN EASY TO USE TOOL KIT AS WELL
AS IDENTIFYINGGAPS IS AN OPPORTUNITY I SEE AND
ONE I WOULD LOVE TO CHAT WITH
FOLKS ABOUT ESPECIALLY IF YOU'VE
ALREADY COME ACROSS WHMAY BE.
FOR THOSE WORKINPRACTITIONERS OR PATIENTS IN THE
PUBLIC THERE MAY BE DIFFERENT
ASPECTS AND WHAT TYPES OF
MATERIALS WOULD BE THE GREATEST
BENEFIT IN COMMUNICATING
PREPRINTS SOME COMES DOWN TO
HELPING FOLKS UNDERSTAND A
SCHOLARLY ARTICLE AND WHAT CAN
WE DO THERE TO HELP PEOPLE
BETTER ASSESS THE QUALITY OF AN
ARTICLE WHETHER IT'S BEEN PEERREVIEWED OR NOT.
AND FINALLY, AS I'VE WE'RE HOPING TO HEAR YOU'RE
FEEDBACK THROUGHOUT THE PILOT
AND WANT TO BE AN ACTIVE
COLLABORATOR AND REALIZE WE
DON'T NECESSARILY INTERACT WITH
THE SAME STAKEHOLDERS AS YOU ALL
SO NLM AND MEDICAL LIBRARY IN
GENERAL OFFERS A BRIDGE TO UNDERSTAND THE RESEARCHER AND
INSTITUTIONAL PERSPECTIVE.
I'M HOPING WE CAN HAVE WONDERFUL
DISCUSSION TODAY AND IN THE
MEANTIME, THANK YOU SO MUCH FOR
YOUR TIME AND INTEREST.
IT'S VERY MUCH A PLEAS CHAT WITH YOU.
THANK YOU.
>> GREAT, KATY, THANK MUCH.
SO I'M GOING GET THINGS
RE-ORGANIZED ON THE SCREEN F MYSELF SO BEAR WITH ME JUST A
MOMENT.
SO THERE ARE A LOT OF QUESTIONS,
KATY.
>> OH, GOOD.
>> I GOT THEM FROM THE CHAT BOX.
A TECHNICAL QUESTION HERE THERE
WAS A QUESTION YOU SAID
SOMETHING A TRANS OPPOSED WHICH
I BELIEVE IS A SERVER OR
SIGNING A DOI.
>> THAT MAY BE MIXING TWO THINGS
AND APOLOGIZE IF I DON'T GET IT
RIGHT BUT TRANSPOSE IS A DATABASE FOR FINDING JOURNAL
POLICY.
FOR EXAMPLE, IF YOU WANT TO KNOW
WHAT THE LANCET JOURNAL PO IS AROUND ACCEPTING PAPER
SUBMISSION HAVE BEEN PREVIOUSLY
POSTED AS A PREPRINT, THAT'S WHERE YOU WANT TO GO.
THE DOI I MENTIONED IS TIED TOJOURNALS AND VERY NEW IN THE BIO
MEDICAL COMMUNITY AND BE AROUND A BIT LONGER IN PHYSICS
AND WHAT HAPPENS IS LIKE ARCHIVE
IS THE REPOSITORY FOR THIS
CONTENT AND THEY CONTINUE TO
HOST IT BUT THE JOURNAL MAY PEER
REVIEW AND SELECT IT AND WILL
ASSIGN AN AD DOI.
THOUGH THE ARTICLE CONTINUES TO
LIVE ON ARCHIVE, AND ACTUALLY,
IT'S THE OPEN JOURNAL OF
ASTROPHYSICS AND THERE'S ANOTHER
ONE CALLED QUANTUM BUT IF YOU
WANT IT GET AN IDEA OF WHAT ANOVERLAY JOURNAL IS, THEY LIVE IN
THIS OVERLAY WORLD OVER
PREPRINTS AND BRIDGE THE GAPBETWEEN PREPRINTS AND JOURNALS.
>> THANKS FOR CLEARING THAT UP.
SO THEN THAT'S ANOTHER QUESTION,
IF A PREPRINT IS IN MY
BIBLIOGRAPHY AND THAT'S LINKED
TO ERA COMMONS, I ASSUME IT WILL
BE AVAILABLE IN THE RPPR TO
SELECT FOR IT AND IS IT
ACCEPTABLE.
>> THAT'S THE NIH
[INDISCERNIBLE].
MY UNDERSTANDING IS, YES.
I DO NOT KNOW WHICH SECTION IT
SHOWS UP IN SO I KNOW THERE'S
VARIOUS C1 TENDS TO BE WHERE THE
PEER-REVIEWED PAPERS SHOW UP.
I'D HAVE TO CHECK WITH A
COLLEAGUE WHETHER THE PREPRINT
WOULD BE PULLED INTO C1 FOR
SELECTION OR WHETHER IT GOES INTO A DIFFERENT SECTION.
BUT IF WE GET THE INDIVIDUAL WHO
ASKED THAT NAME I'M HAPPY FIND OUT.
>> OKAY, GOOD, THANK YOU.
THEN THIS IS A QUESTION I THINK
APPEARED A COUPLE OF TIMES, WILL
THE PREPRINT BE REMOVED AFTER
ACCEPTANCE/PUBLICA THERE BE A PERMANENT DATE
ASSOCIATED WITH THE PREPRI DATE AND IN PARENTHESIS THE
PERSON SAID I HOPE.
>> WE'LL MAINTAIN THE PREPRINT
RECORD AND THE PUBLISHER RECORD
IN PMC IF WE HAVE THEM BOTH.
IF WE ONLY HAVE THE PREPRINT WE
WOULD POINT TO THE PUBLIRSION EITHER ON THEIR SITE OR
IN PUBMED.
SO -- I APOLOGIZE.
MY DAUGHTER JUST ENTER AREA.
SO YES, WE WILL BE ACTING IN OUR
ROLE AS AN ARCHICONTINUING TO KEEP THAT CONTENT
IN PMC.
>> OKAY AND THEN THERE'S ONE,
WILL THERE BE ACCESS TO THE FULL
TEXT OF PREPRINTS.
>> YES.
THE WAY WE FORESEE THIS WORKING
IS THAT WE WILL CREATE [INDISCERNIBLE] RECORD THE
TITLE, CITATION AND AUTHORS
INITIALLY AND WE WILL INCLUDE A
LINK TO THE PDF.
THAT WILL BE IN PMC.
AS SOON AS WE PULL IT INTO PMC
WE ARE ALSO GOING TO SEND IT OUT
FOR XML CONVERGE TO HAVE AN
ARCHIVAL COPY IN XML THAT
MIRRORS THE PRESENTATION OF ALL
OF OUR OTHER CONTENT AND MAKES
IT MORE MACHINE READABLE.
A FEW DAYS AFTER TUP IN PMC IT WILL BE REPLACED BY
A FULL TEXT HTML VERSION.
>> SORRY, I WAS MUTED.
>> I WAS LIKE PROFOUND THAN I THOUGHT.
>> SILENCE.
IS THIS PREPRINT PILOT PROJECT
OPEN TO CANADA RESEARCHERS?
>> FOR THEM TO CONTRIBUTE
CONTENT THERE NEEDS TO BE NIH
SUPPORT.
THERE ARE SOME CAS CANADA RESEARCHERS EITHER
COLLABORATE WITH NIH RESEARCHERS
OR HAVE NIH SUPPORT THEMSELVES.
THE CONTENT THAT IS AVAILABLE THOUGH WILL BE MADE
AVAILABLE BROADLY.
NOW, AS TO WHETHER YOPEN THIS UP TO ACCEPT PREPRINTS
FUNDED BY SAY CCIHR OR IN EUROPE
LIKE THE WELCOME TRUST, THAT IS
WE CONSIDER WHERE AT THE END OF
THE PILOT WE CONTINUE TO PURSUE
INCLUSION OF PREPRINTS AT PMC.
AT THIS POINT BECAUSE IT IS NEW
TO US AND BECAUSE PREPRINTS ARE
STILL ARE NOT PERHAPS TH WEST STILL GETTING SORTED WE
WANT TO TAKE A VERY CONTROLLED
ENTRY INTO THIS REALM.
>> OKAY.
AND THEN SO THERE'S -- I'VE GOT
TWO QUESTION GO TO THE SAME
THING.
ONE IS WHEN DO YOU EXPECT
PREPRINTS TO SHOW UP IN PMC AND
WILL YOU BE MAKING INTERIMREPORTS ON THE PILOT PROJECTS.
I GUESS THEY SORT OF GO
TOGETHER.
>> SO MY HOPE IS THAT THOSE
PHASE 1 COVID-19 PREPRINTS WILL
SHOW UP NEAR THE MONTH.
WE'RE VERY CLOSE TO HAVING ALL
THE PIECES IN PLACE BUT WE DO
NEED TO BRING THEM ALL TOGETHER
AND WE WANT TO SORT OF ENSURE WE
HAVE AN OPPORTUNITY COMMUNICATE WITH THE VARIOUS
STAKEHOLDER GROUPS.
WE'RE ABLE TO TALK TO YOU GUTODAY AND WE'VE BEEN TALKING TO
A FEW PREPRINT SERVERS AND WE
WANT TO MAKE SURE RESEARCHERS
ARE AWARE THEI UP THIS WAY.
I WOULD SAY IT'S GOING TO BE A
FEW WEEKS BUT HOPEFULLY BEFORE
MAY 30.
WHAT WAS THE SECOND QUESTION?
OH, INTERIM REPORTS.
THAT'S A GREAT QUESTION.
ONE I THINK LIKELY MAKES SENSE.
WHAT FORMS THAT TAKES I DON'T
KNOW WHETHER IT'S A TECHNOLOGY
IN OR A MORE FORMAL
ENGAGEMENT LIKE THIS IS
SOMETHING WE CAN DISCUSS.
THANK YOU FOR RAISING IT.
>> ALL RIGHT.
I THINK I'M GOING TO ASK ORE HERE BECAUSE WE HAVE OTHER
QUESTIONS FOR THE GROUP.
THIS PERSON WROTE A CUSTOMASKED ME RECENTLY WHETHER
POSTING TO A PREPRINT SERVER IS
CONSIDERED PUBLISHED.
THE PERSON SAID IN THE QUESTION,
I KNOW YOU BRIEFLY TALKED ABOUT
PROS AND CONS BUT CAN YOU SAY A
BIT MORE ABOUT THIS ISSUE.
>> SURE.
I FEEL LIKE A LOT OF THIS COMES
DOWN TO PERSONAL BELIEFS IN VIEW, YES.
ONCE YOU HAVE MADE AN ARTICLE
PUBLICLY AVAILABLE IT IS
PUBLISHED.
PUBLISHED IS A LOADED WORD AND
WHY I THINK DATABASE TRANSPOSED
IS A USEFUL TOOL TO BE AWARE OF.
IF YOUR PAPER WAS PUBLISHED
ELSEWHERE IT WOULD NOT BE
CONSIDERED BY A JOURNAL FOR
PUBLICATIO MANY, MOST JOURNALS HAVE SINCE
TAKEN THE POSITION THAT POST
PREPRINT DOES NOT AFFECT YOUR
ABILITY TO SUBMIT TO THAT
JOURNAL.
SO IN THAT REGARD WHICH IS MAYBE
WHAT THE RESEARCHER WAS ASKIOUT POSTING A PREPRINT DOES
NOT REPRESENT PUBLICATION.
BUT THERE ARE SOME JOURNALS WHO
DO STILL TAKE THAT SORT OF
APPROACH.
I DON'T WANT TO MISTAKENLY CALL
ANYBODY OUT.
FOR A WHILE THE NEW ENGLAND
JOURNAL OF MEDICINE -- A THERE'S GOING TO BE PEOPLE ON
THE PHONE WHO KNOW THIS BETTER
THAN ME, I WOULD JUST RECOMMEND
YOU CHECK THE JOURNAL'S WEBSITE
OR THAT TOOL WHETHER THEY DEFINE
IT AS A PUBLICATION OR NOT.
>> I SUPPOSE IF THEY'RE ON TENURE TRACK NOBODY WANTS TO
FIGURE THAT OUT.
>> I THINK RESEARCHERS NEED TOBE MADE AWARE A LOT OF JOURNALS
DON'T CONSIDER IT
PRE-PUBLICATION BU AWARE SOME DO.
THAT'S A KEY AREA OF EDUCATION
TO TAKE PLACE.
>> OKAY.
I'M LOOKING IN THE CHAT BOX NOW
JUST TO SEE IF THERE'S ANYTHING
ELSE THAT WE -- AND YOU CAN SEE
THAT CHAT BOX TOO, KATY.
SO WHAT WE WANT TO DO NOW ISWE'VE GOT SOME QUESTIONS WE WANT
TO POSE TO YOU AND I'LL ADVANCE
MY SLIDE HERE.
WE'D LIKE TO USE THE CHAT BOX
AND I KNOW SOME OF YOU AS WE GET
TO THE QUESTIONS YOU MAY HAVE
ALREADY PUT YOUR COMMENTS IN YOU
WERE AHEAD OF THE GAME.
BUT FEEL FREE TO PUT YOUR
COMMENTS IN AGAIN.
REMEMBER TO SEND TO ALL
PARTICIPANTS.
WHAT ARE THE BENEFITS FOR
PREPRINTS FOR YOU AND YOUR
COMMUNITY IN YOUR DISCIPLINE OR
OUR ORGANIZATION?
WHAT DO YOU THINK ARE THE KEY
BENEFITS TO THE PROJECT.
>> THIS IS HAPPENING SO FAST.
>> I'LL TRY TO RECAP AS THEY
COME IN.
MAY HELP WITH NEW GUIDELINE
PROTOCOL INITIATIVES.
ANYTHING ELSE YOU WANTS TO TALK
MORE ABOUT KATY, IF YOU SEE
SOMETHING.
RAPID ACCESS IS COMING UP A LOT.
STRIKING CLAIM, GETTING CREDIT.
THERE WAS A QUESTION ABOUT INCLUDING -- LET ME FIND THAT.
I WOULD LOVE TO KNOW YOUR
THOUGHTS ON THE INCLUSION OFPREPRINTS IN SYSTEMATIC REVIEW
SEARCHS.
>> I'M SURE THERE'S PEOPLE ON
THE CALL BETTER QUALIFIED TO
SPEAK TO THAT.
I'M SURE THAT'S SOMETHING FOR
THE SYSTEMATIC REVIEW COMMITTEE.
I WAS ON AN INTERESTING CALL
THIS MORNING THAT INVOLVED
COCHRAN AND CAMPBELL AROUND
COVID-19 AND THEIR GRAPPLING WITH THIS THEMSELVES AT THIS
TIME.
THEY DO WANT THEIR REVIEWS TO
REFLECT THE MOST CURRENT
RESEARCH AND THEY'RE GRAPPLING
WITH WHAT THAT MEANS AS FAR AS
IF IT'S NOT PEER REVIEWED.
I THINK THERE'S A POTENTIAL
VALUE IN POSTING THE PREPRINT
AND MAYBE YOU CAN CHECK, THERE'S
A LOT OF WAYS FOR PEOPLE TO
COMMENT ON PREPRINTS AND WHILE
IT'S NOT FORMAL PEER REVIEW IT
COULD AN INDICATION OF THE
OVERALL QUALITY AND AS A
DATABASE SCHOLARLY
COMMUNICATIONS PERSON AND NOT A
SYSTEMATIC REVIEW PERSON, I
HESITATE FOR ANYONE TO TAKE THAT
AS GOSPEL.
IT'S AN AMAZING CONVERSATION
THAT NEEDS TO HAPPEN AND WOULD
LOVE TO SEE THAT UNFOLD.
>> ONE PERSON MADE A COMMENT,
PREPRINTS WOULD BE GREAT AND IN
THE PROTOCOL YOU ESTABLISHED FOR
THE SYSTEMATIC REVIEW YOU'D HAVE
TO DECIDE WHETHER OR NOT TO
INCLUDE THEM OR NOT.
ONE PERSON SAID OUR LIBRARY HAS
A FEDERATED SEARCH OF PREPRINTS
AND IT'S POPULAR AMONG
RESEARCHERS.
TAKING A CLAIM.
WE TALKED ABOUT THAT.
ESTABLISHING CONTENT BELONGS TO
THE RESEARCHER BEFORE THEY SIGN
IT AWAY.
ONE PERSON SAID IT'S GRAY LIT.
SO WE GOT BENEFITS THERE.
OKAY.
LET'S MOVE ON TO THE NEXT
QUESTION.
THIS IS A TWO-PART QUESTION, WHAT ARE YOUR CONCERNS ABOUT
PREPRINTS AND WE HAVE SEEN A LOT
OF THAT IN THE CHAT BOX ALREADY
BUT PLEASE REITERATE AND WHAT
TYPES OF INFORMATION OR
RESOURCES WOULD HELP YOU ADDRESS
YOUR CONCERNS AND I THINK I SAW
WITH REGARDS TO THE QUESTION OF
PROGRESS ABOUT YKATY, SOMEBODY MENTIONED
SOMETHING ABOUT PUTTING
ANNOUNCEMENTS IN THE BULLETIN
AND PEOPLE SECONDED THAT.
WE'RE SEEING NOW CONCERNS.
>> SO CATALOG.
WE'LL HAVE A CATALOG ENTRY FOR THE PREPRINT SERVERS WE WORK
WITH AND THE METADATA AT THE
ARTICLE LEVEL AND WILL TRY TO
MAKE SURE PREPRINT IS INDICATED
IN ALL THAT VERSION CONTROL.
HELLO, DONNA, THIS STRESSE OUT AS WELL.
WE'VE ADDED SORT OF THIS LINE IN
THE PMC VIEW TO MAKE SURE THAT
READERS ARE MADE AWARE VERSIONS
MAY EXIST AND TRYING TO GET THEM
TO LOOK AT IT ON THE PREPRINT
SERVER'S WEBSITE TO MAKE SURE
THEY'RE GETTINCOMPLETE PICTURE AND WORKING ON
OUR END STILL ON V TRANSPARENCY AND WHATEVER WE
RENDER VERSION.
THERE'S THE VERSION CONTROL AND
PREPRINT AND THERE'S ALSO GOING
TO BE THE ISSUE WITH THE
PREPRINT AND THE PUBLISHER TO
PUBLISH THE REPORTS COEXISTING.
I'VE BEEN INVOLVED IN
CONVERSATIONS HOW YOU MEASURE
THE IMPACT OF AN ARTICLE ACROSS
ALL VERSIONS.
YOU WANT THE FEASIBILITY DATA
WITH THE THE PREPRINT AND THE IMPACT AND SOMETHING WE'LL
HAVE TO KEEP WORKING OUT.
IT'S DEFINITELY AN EVOLVING
LANDSCAPE.
THEN THERE'S VISIBILITY OFRETRACTED PREPRINTS.
>> THIS IS EXTREMELY IMPORTANT
TO US.
IT'S WHY WE ARE BEING FAIR CAREFUL WHICH PREPRINT SERVERS
WE'LL WORK WITH.
WE'RE HANDLING THIS AS A
SCHOLARLY RESEARCH OBJECT.
WE WOULD EXPECT IF THE PREPRINT
WAS RETRACTED OR SOMETIMES THEY
USE DIFFERENT LANGUAGE IN
PREPRINT WORLD, WITHDRAWN, THERE
WOULD BE THERE WOULD BE RECORD
XPLAINS THIS WAS THIS WAS
RETRACTED ON THIS DATE FOR THIS
REASON AND GO TO THE TEXT OF THE
PREVIOUS VERSION OR ANY PREVIOUS
VERSIONS TO MAKE IT THAT VERSION IS NO LONGER OR
THAT PREPRINT ITSELF IS NO
LONGER CONSIDERED VALID FOR
WHATEVER REASON DESCRIBED.
WE WOULDN'T DISAPPEAR THE
PREPRINT JUST LIKE WE WON'T
DISAPPEAR A RETRACTED
PEER-REVIEWED ARTICLE BUT WILL
CLEAR IT'S RETRACTED OR
WITHDRAWN.
WILL THEY HAVE A CORRESPONDING
RECORD IN PUBMED, YES, WE
ANTICIPATE THIS AS USUAL SO ANYTHING
DISCOVERABLE IN PMC IS ALSO
DISCOVERABLE IN PUBMED.
THEY'LL ALSO HAVE THE OPTION TO
FILTER THEM OUT BUT BECAUSE THE
EMPHASIS FOR NIH IS INCREASING DISCOVERABILITY, WE
KNOW THAT'S WHERE PEOPLE SEARCH
SO IT'S IMPORTANT TO US THEY'RE
THERE TOO.
I KNOW THAT WILL BE SOMEWHAT
CONTROVERSIAL BUT I'M HOPING WE
CAN MAKE IT SO IF YOU DON'T WANT
TO SEE THEM YOU DON'T HAVE TO
AND IT WILL CARRY BANNER PRESENTATION AS WHAT I
SHOWED IN PMC.
I DON'T HAVE A MOCK-UP OR SCREEN
SHOT OF THAT YET BUT THAT'S THE
PLAN.
>> SOMEBODY SENT ME ANOTHER
QUESTION HERE AND THOUGHT IT WASN'T ANSWERED AND I THINK
SHE'S CORRECT.
SO COULD YOU EXPLAIN, KATY, A
LITTLE BIT ABOUT ONCE A
PUBLICATION BASED ON A PREPRINT
COMES OUT WHO'S RESPONSIBILITY IS IT TO PUT IT TO THE
META-ARCHIVE IS LINKING TO A
PUBLISHED VERSION MANDATORY OR
OPTIONAL ON THOSE PLATFORMS?
>> SO IDEALLY IN THE PERFECT
WORLD THE AUTHOR WOULD SUBMIT
THERE'S A PREPRINT AVAILABLE AND
PROVIDE THE DOI AND BECOME PART
OF THE RECORD AND THE METADATA
WOULD BE THERE.
IN THAT REGARD IT'S ALWAYS ON
THE AUTHOR TO MAKE SURE THE
JOURNAL KNOWS THERE'S A PREPRINT
THAT HAS BEEN POSTED.
IT IS THEN ONCE THE JOURNAL AWARE KIND OF UP TO THEM TO MAKE
SURE THAT THAT LINK IS MADE.
THAT BEING SAID, S DO THIS WELL AND SOME DO NOT.
WHEN THE JOURNALS DO THEY
GENERALLY PROVIDE THAT DATA TOCROSS REF.
THAT'S ONE TO FIND THE LINKS AND
THE ONE THING WE C COLLEAGUES AT EUROPE PMC HAVE
BEEN DOING IS LOOKING AT RUNNING
TITLES OF PREPRINTS VERSUS
TITLES OF PUBLISHED ARTICLES AND
COMPARING THE AUTHOR LIST AS WELL AND WHEN THEY GET A MATCH
THEY BUILD THAT LINK AS WELL.
SO THERE'S REALLY TWO WAYS THIS
IS HAPPENING BUT IN THE PERFECT
WORLD IT WOULD BE THE SORT OF
AUTHOR'S RESPONSIBILITY NOTIFY THE JOURNAL AND THE
JOURNAL TO NOTIFY ANY INDEXING
SERVICES.
>> OKAY.
AND THERE WAS A
COMMENT/QUESTION.
YOU MENTION THE PREPRINTS WILL BE CURATED BEFORE POSTING.
WHAT WILL BE ASSESSED DURING THE
CURATION PROCESS?
>> THIS IS DOING TO BE A CHECK FOR NIH SUPPORT AND WE'LL
PROBABLY WANT IT TO BE FAIRLY
DIRECT AND RECENT NIH SUPPORT.
WE HAVE RUN INTO PROBLEMS WITH
PEOPLE REPORTING PAPERS AS
PRODUCTS OF AWARD FOR DEDICATED
TO GET THEIR PAPERS INTO PMC AND
PUBMED.
WE'RE LOOKING FOR AN ACTIVE
AWARD AND THIS IS AN NIH-FUNDED
RESEARCHER, THIS IS IN APREPRINT SERVER CONSISTENT WITH
OUR GUIDELINES.
WE WILL NOT DO PEER REVIEW OFMATERIAL OF OURSELVES SO IT WILL
BE SOMEWHERE IN BETWEEN WHAT WE
DO FOR MANUSCRIPTS WHICH IS
WE'LL TAKE ANY MANUSCRIPT FUNDED
BY NIH REGARDLESS OF WHERE IT'S
PUBLISH AND WHAT WE DO ON THE
JOURNAL SIDE WHICH IS YOU MUST
MEET CERTAIN CRITERIA.
THIS IS MORE OR LESS WE WILL
PRINTS FROM NIH SUPPORT
FROM PREPRINT SERVERS THAT MEET
CERTAIN CRITERIA AND THAT'S THE
SWEET SPOT WE'RE LOOKING FOR.
>> I'M GOING TO WRAP UP THIS
QUESTION ON THE SLIDE AND MOVE
ON TO ANOTHER ONE WHAT
OPPORTUNITIES SURROUNDING
PREPRINTS DO YOU ALL IN THE
AUDIENCE TODAY SEE LIBRARIANS.
HAS ANYBODY LED A SESSION, A
LUNCH AND LEARN OR ANYTHING LIKE
THAT.
THERE'S A QUESTION/OPPORTUNI FROM SUSAN SANDERS.
SHOULD WE BE REACHING OUT TO OUR
NIH RESEARCHERS TO ASK IF THEY
HAVE PREPRINT VERSION OF THEIR
RESEARCH AND HOW WOULD THEY
SUBMIT ONE NOW?
>> THAT'S A GREAT QUESTION.
I HAD A MOMENT AT 5:00 A.M. THIS
MORNING TO MAKE IT MORE
EXPLICIT.
ONCE WE HAVE DOCUMENTATION UP
AND SOMETHING FROM THE OFFICE OF
EXTRAMURAL RESEARCH IT WOULD BE
AMAZING IF YOU ALL COULD ENGAGE
YOUR NIH-FUNDED RESEARCHERS AND
ENCOURAGE AND EDUCATE THEM ABOUT
PREPRINTS AND ENCOURAGE THEM TO
POST PREPRINTS.
THEY SHOULD NOT THROUGH ANY SORT OF SUBMISSION
PROCESS THOUGH.
WHAT WE'RE ASKING FOR IS FOR
THEM TO GO INTO MY BIBLIOGRAPHY,
SAY THIS IS MY PREPRINT AND YOU
GO IN AND INSTEAD OF ARTICLE YOU SELECT INTERIM
RESEARCH PRODUCT AND A PREPRINT
IS SOMETHING YOU CAN ADD THAT
WAY.
THAT'S ONE OF THE THINGS WE WANT
TO IMPROVE.
ESSENTIALLY YOU ADD THATCITATION TO MY BIBLIOGRAPHY AND
YOU CAN ASSOCIATE YOUR N AWARDS AND WE THEN KNOW THE
PREPRINT HAS NIH SUPPORTED.
IF IT'S NOT A COVID-19 PREPRINT
IT WON'T SHOW UP RIGHT AWAY BUT
THOSE ARE THE ONES WE'LL BE
COMING BACK AND TRYING TO IN THE FUTURE PHASES OVER THE
SUMMER.
REALLY, IF YOU CAN ENCOU YOUR RESEARCHERS, CITE YOUR
PREPRINT IN MY BIB AND ASSOCIATE
YOUR AWARDS AND SUBMIT YOUR
CREATIVE COMMONS LICENSE.
THAT IS A WONDERFUL START.
I'M GOING TO THE LAST QUESTION
WE HAVE.
AFTER THIS LAST QUESTION WE HAVE
AN EVALUATION QUESTION WITH A
CODE FOR MLA/CE.
WHAT SHOULD A PILOT FOR PREPRINTS LOOK LIKE TO
YOU FOLKS IN THE AUDIENCE?
WHAT SHOULD IT LOOK LIKE?
ANNOUNCEMENTS, EDUCATIONAL
TOOLS, SOME SORT OF A TOOL KIT
TO SHARE WITH FOLKS.
MAKE IT A FILTER IN PUB MED.
I'M MISSING SOMEBODY'S CONCERNS
BUT I CAN'T FIND THAT.
>> WILL WE HAVE A TRANSCRIPT?
>> YES, WE'LL COPY THAT.
TOOL KIT WOULD BE BENEFICIAL.
WE SEE THAT.
PLEASE WRITE OUT AN THE PROCEDURE RESEARCHERS SHOULD
FOLLOW IF THEY WANT TO ASSOCIATE
IT WITH MY BIB --
>> THANK YOU.
THE OFFICE OF EXTRRESEARCH HAS ACTUALLY REQUESTED
AND I'M LOOKING AT THE FLOW
CHART HOW WE ASSOCIATE IT WITH MY BIB AND WE'LL HAVE A VIDEO
NICE AND SHORT AND EASY FOR YOU
TO SHARE OR FLOW CHART.
FLOW CHARTS ARE GOOD TOO.
>> PUBLIC-FACING INFORMATION.
STEP BY STEP AND CLEAR.
YES, VIDEOS ARE GREAT.
TRANSPARENT INFORMATION TO SHARE
WITH RESEARCHERS.
SOMEBODY WAS SECONDING SOMEBODY
ELSE'S CONCERNS, I WANT TO GO
BACK TO THAT.
CONFUSING TO SEARCHERS OF PUBMED
IT CONTAINS SO MANY CATEGORIES OF CONTENT, MEDLINE AND INDEX
AND I'D LIKE IT TO BE CLEARER TO
USERS TO LIMIT TO MEDLINE INDEX
IF THEY WANTED.
THAT'S A GREAT OPPORTUNITY FOR LIBRARIANS.
I UNDERSTAND INCREASDISCOVERABILITY FOR MANY
SITUATIONS BUT I SEE MANY
RESEARCHERS WHO CAN'T REVIEW ALL
AND WANT TO LIMIT TO RESEARCH
AND QUALITY CONTROL LIKE
PEER-REVIEWED JOURNALS.
>> THANK YOU FOR THE FEEDBACK.
WE WANT TO LAUNCDESCRIBED BUT THIS IS SOMETHING
WE'RE AWARE OF AND WE WILL BE
INTERESTED IN HEARING BACK ON
WHETHER IT'S -- I THINTHINKING THROUGH THE BEST WAY TO
PROCEED.
PLEASE SEND YOUR F THIS GOES ESPECIALLY WHAT YOUR
HEARING FROM RESEARCHERS.
YOU'RE WELCOME TO TWEET AT US.
I'M NOT A TWEETER SO IT'S BETTER
TO CATCH ME VIA EMAIL BUT WEWILL WANT TO KNOW AND WHETHER WE
START PROVIDING NEW FACETS IN
NLM OR IN PUBMED TO MAKE IT
SIMPLER FOR PEOPLE OR JUST MAKE
IT MORE VISIBLE FROM THE SEARCH
RESULTS FOR THOSE OF YOU WHO
USED EUROPE PMC THEY DO MAKE IT
CLEAR WHICH IS A PREPRINT IN THE
RESULTS VIEW.
THERE'S A FEW EXPLORE IN KNOWING WHAT PROBLEMS
YOU OR YOUR RESEARCHERS RUN INTO
WE HOPEFULLY CAN RESPOND TO
THOSE.
>> ALL RIGHT.
IN REGARDS TO A SUCCESSFUL PILOT
AND WE TALKED ABOUT A VIDEO AND
BEING ABLE TO UPLOAD THOSE TO A
LEARNING MANAGEMENT SYSTEM.
I DON'T KNOW FOLKS WHO USE AN
LMS LINKED TO A VIDEO OR WANT
THE PACKAGES SOMETHING TO KEEP IN MIND ON YOUR END, KATY.
>> I THINK USUALLY OUR VIDEOS
ARE POSTED TO YOUTUBE.
IF THAT'S NOT THE IDEAL FORM LET ME KNOW AND WE'LL TRY TO
COME UP WITH MULTIPLE WAYS OF
MAKING IT AVAILABLE.
>> AND THEY WILL BE CLOSED
CAPTIONED BECAUSE THAT IS
REQUIRED FOR NIH STUFF.
OKAY.
>> SOMEONE ASKED FOR MY E-MAIL
ADDRESS.
FIND ME AT KATHRYN.FUNK@NIH.gov.
I CAN TYPE THAT IN.
>> SOME PEOPLE HAVE TO GO.
THERE'S A LINK TO THE
EVALUATION, IF YOU WANT MLA/CE
HE EVALUATION.
THE LAST QUESTION ON THE
EVALUATION ASKS YOU IF YOU WANT
CE.
IF YOU ANSWER QUESTION AND I HAVE A PICTURE OF IT ON THE
SLIDE IN THE GREEN IF YOU ANSWER
YES, THE LOW COLORED AREA WILL OPEN UP AND
NUMBER 4 WILL SHOW AN ENROLLMENT
CODE FOR YOU TO COPY, WRITE
DOWN, WHATEVER YOU HAVE TO MLA.org AND YOU DON'T HAVE TO
BE A MEMBER BUT YOU'ACCOUNT TO CLAIM YOUR CE AND 1.5
CREDITS FOR TODAY.
THANK YOU FOR COMING.
I THOUGHT IT WENT WELL AND THANK
YOU FOR YOUR PARTICIPATION ANDFEEDBACK AND WE'LL SEE YOU NEXT
>> THANK YOU.
>> THANK YOU, KATY.
>> THANK YOU.